US Broker Ratings

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Biotech with 97% Potential Upside

Nurix Therapeutics, Inc. (NRIX) is making waves in the biotechnology sector with its promising pipeline of innovative therapies targeting cancer and inflammatory conditions. With a market capitalization of $1.57 billion,..

Evolus, Inc. (EOLS) Stock Analysis: Unpacking a Potential 159% Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS), a burgeoning player in the healthcare sector, is capturing investor attention with its impressive potential upside of 159.13%, according to analyst target price ranges. Specializing in..

CeriBell, Inc. (CBLL) Stock Analysis: A 55% Potential Upside Amid Strong Buy Ratings

CeriBell, Inc. (NASDAQ: CBLL) is capturing significant attention in the healthcare sector, particularly within the medical devices industry. This United States-based company, with a market capitalization of $673.4 million, is..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A 40.95% Upside Potential in the Biotech Sector

Investors seeking promising opportunities in the biotechnology sector might find Enliven Therapeutics, Inc. (NASDAQ: ELVN) particularly intriguing. With a current market capitalization of $1.74 billion, this Boulder, Colorado-based company is..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: A High-Risk, High-Reward Bet in Gene Editing with 92% Upside Potential

Intellia Therapeutics, Inc. (NASDAQ: NTLA) is capturing the attention of investors with its cutting-edge approach to genome editing. As a clinical-stage company, Intellia is at the forefront of developing potentially..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 21.60% Upside Potential Amidst Clinical Innovations

Arbutus Biopharma Corporation (NASDAQ: ABUS), a prominent player in the biotechnology sector, is capturing investor attention with its promising clinical-stage therapeutics and a notable 21.60% potential upside. Headquartered in Warminster,..

Anavex Life Sciences Corp. (AVXL) Investor Outlook: Exploring a Potential 362% Upside in Biotech

Anavex Life Sciences Corp. (NASDAQ: AVXL), a biopharmaceutical company headquartered in New York, is making waves in the biotechnology sector with its innovative approach to treating central nervous system (CNS)..

Arcus Biosciences, Inc. (RCUS)

⚠️ No article content returned.

..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 76% Potential Upside in the Healthcare Sector

For investors keen on tapping into the healthcare sector, Embecta Corp. (NASDAQ: EMBC) offers an intriguing proposition with a potential upside of 76.55%. This Parsippany, New Jersey-based medical device company..

Praxis Precision Medicines (PRAX) Stock Analysis: A Biotech with 93% Upside Potential

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) presents a compelling opportunity for investors looking to capitalize on the burgeoning biotechnology sector. With its focus on developing precision therapies for central nervous..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a Potential 153% Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Nuvation Bio Inc. (NYSE: NUVB) an intriguing prospect, especially given its impressive potential upside. With a current market cap of..

Beta Bionics, Inc. (BBNX) Stock Analysis: A Promising Growth Potential with a 110.77% Upside

Beta Bionics, Inc. (NASDAQ: BBNX), a dynamic player in the healthcare sector, is capturing the attention of investors with its innovative approach to diabetes management. The company, based in Irvine,..

Weave Communications, Inc. (WEAV) Stock Analysis: Unveiling a Significant 57.94% Upside Potential

Weave Communications, Inc. (NYSE: WEAV) is garnering attention from investors, thanks in part to its substantial 57.94% potential upside, according to analyst ratings. Specializing in health information services, Weave Communications..

Xeris Biopharma Holdings, Inc. (XERS): Investor Outlook on a High-Potential Biotech Stock with 84% Upside

Xeris Biopharma Holdings, Inc. (XERS), a dynamic player in the biotechnology industry, is attracting attention from investors due to its promising drug portfolio and substantial growth potential. With a market..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Unlocking a 54.3% Upside Potential in Biotech

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a burgeoning player in the biotechnology sector, is making waves with its promising pipeline of cancer therapies. Based in Newtown Square, Pennsylvania, this clinical-stage biopharmaceutical..

Gyre Therapeutics, Inc. (GYRE) Investor Outlook: Exploring a Promising 138% Upside Potential

For investors eyeing the biotechnology sector, Gyre Therapeutics, Inc. (NASDAQ: GYRE) offers a compelling opportunity with a significant upside potential. With its current stock priced at $7.83 and a consensus..

Phibro Animal Health Corporation (PAHC): Investor Outlook with Strong Revenue Growth and Strategic Positioning

Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a noteworthy player in the healthcare sector, particularly within the specialized domain of drug manufacturing for animal health. With a diverse portfolio..

CureVac N.V. (CVAC) Stock Analysis: Navigating the mRNA Market with a $1.05 Billion Market Cap

As of December 18, 2025, CureVac N.V. completed its acquisition by BioNTech SE, marking a significant milestone in the company’s journey within the competitive biotechnology sector. Based in Tübingen, Germany,..

InMode Ltd. (INMD) Stock Analysis: Exploring a 24.91% Potential Upside in the Medical Device Sector

InMode Ltd. (NASDAQ: INMD) stands out in the healthcare sector as a promising player within the medical devices industry. Headquartered in Yokne’am, Israel, InMode specializes in developing and marketing cutting-edge..

Nutex Health Inc. (NUTX) Stock Analysis: A High Upside Potential with a 137.33% Gain on the Horizon

Nutex Health Inc. (NASDAQ: NUTX), a dynamic player in the healthcare sector, offers a compelling opportunity for investors seeking exposure to the medical care facilities industry. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds